Drug Approval Package
-
NovoLog (Insulin Aspart [rDNA origin]) Injection
Company: Novo Nordisk Pharmaceuticals, Inc.
Application No.: 20-986/S-003
Approval Date: 12/21/2001
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Medical Review(s) (PDF)
-
Chemistry Review(s) (PDF)
-
Correspondence (PDF)
Date created: July 25, 2002
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-